Eli Lilly and Company Profit Margin

As of the most recent data (June 2026), LLY.DE shows a profit margin of 33.53%. That compares with 25.91% in the prior-year period — up 29.4% year over year. That is above the Healthcare sector average of 9.71%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LLY.DE's profit margin is now 33.53% (was 25.91%) — a 29.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Eli Lilly and Company is outperforming or lagging.

The Healthcare sector average profit margin is about 9.71%. Eli Lilly and Company is at 33.53%, which is higher that average. That is roughly 245.4% above the sector mean. Use the comparison chart on this page to see how LLY.DE stacks up against individual peers as well.

That compares with 25.91% in the prior-year period — up 29.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Eli Lilly and Company with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Eli Lilly and Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 33.53%) with ownership activity and broader fundamentals.